Oncology
The word oncology comes from the Ancient Greek term ónkos, which means tumor or bulk. It also derives from lógos, meaning study. This branch of medicine deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices this field is called an oncologist. The scope covers everything from screening people who may have cancer to monitoring patients after treatment ends. Ethical questions surrounding cancer care form a core part of the discipline's daily work.
Medical histories serve as important screening tools to assess nonspecific symptoms like fatigue or unexplained anemia. Diagnostic methods often include a biopsy where suspicious neoplastic cells are removed for examination by a pathologist. These cells can be taken in part or in whole to determine malignancy. Other procedures involve endoscopies such as upper gastrointestinal scopes or bronchoscopies to localize tissues. Mammograms, X-rays, CT scanning, MRI scanning, and ultrasound help guide these biopsies. Scintigraphy and positron emission tomography identify areas suspicious of malignancy through nuclear medicine techniques. Blood tests including tumor markers assist in diagnosing certain types of cancers. A tissue diagnosis remains essential for proper classification even when empirical therapy becomes necessary.
Certain disorders like acute lymphoblastic leukemia require immediate admission and chemotherapy protocols. Often surgery attempts to remove a tumor entirely but only works if there is certainty about feasibility. When parts remain, curative surgery becomes impossible due to metastases or vital structure invasion. Occasionally debulking improves survival by reducing overall tumor tissue amounts. Chemotherapy and radiotherapy act as first-line radical therapies in several malignancies. They also function as adjuvant therapy after macroscopic tumors have been surgically removed. Hormone manipulation stands well established particularly in breast and prostate cancer treatments. Monoclonal antibody treatments include Rituximab for lymphoma and Trastuzumab for HER2-positive breast cancer. Cancer vaccines and checkpoint inhibitors remain active areas of research and clinical application today.
Although many cancers can be treated to remission with radical treatment, ongoing issues persist. Pediatric patients often face higher numbers of successful outcomes yet still deal with progressive disease symptoms. Problems may include pain, nausea, anorexia, fatigue, immobility, and depression affecting daily life. Personal dignity may suffer alongside strictly physical ailments during the course of illness. Moral and spiritual issues become important components of patient care experiences. Palliative care has matured into a separate closely allied specialty to address these advanced disease problems. This discipline forms an essential part of the multidisciplinary cancer care team working alongside oncologists.
Recurring ethical questions plague oncological practice regarding what information to give patients about prognosis. Decisions about entry into clinical trials arise especially when facing terminal illness situations. Withdrawal of active treatment creates complex emotional scenarios for families and medical teams. Do Not Resuscitate orders represent another layer of end-of-life issues requiring careful navigation. These matters relate closely to the patient's personality, religion, culture, and family life dynamics. Answers are often achieved by seeking counsel from trusted personal friends and advisors outside the hospital. The oncology team requires sensitivity and very good communication skills to address these problems properly without causing harm.
Tremendous research continues ranging from cancer cell biology to optimal palliative care methods. Next-generation sequencing and whole-genome sequencing have completely changed understanding of cancers globally. Identification of novel genetic or molecular markers will change diagnosis and treatment methods significantly. Personalized medicine paves the way forward through these scientific breakthroughs. Therapeutic trials involve patients from many different hospitals in particular regions across nations. In the UK, large studies coordinate Cancer Research UK, Medical Research Council, European Organisation for Research and Treatment of Cancer, and National Cancer Research Network. Most valued companies worldwide include Pfizer, Roche, Merck, AstraZeneca, Novartis, and Bristol-Myers Squibb. These corporations remain active in kinase inhibitors, antibodies, immuno-oncology, and radiopharmaceuticals sectors.
Four main divisions structure clinical practice into distinct areas of focus. Clinical oncology treats cancer with both systemic therapies and radiation techniques. Medical oncology focuses on chemotherapy, targeted therapy, immunotherapy, and hormonal therapy approaches. Radiation oncology concentrates solely on treatment using radiation beams. Surgical oncology handles all procedures involving physical removal of tumors. Sub-specialties expand this framework further including adolescent and young adult oncology. Bone and musculoskeletal oncology targets cancers of bones and soft tissue specifically. Breast oncology addresses cancers of breast tissue exclusively. Cardiooncology emerges as a branch addressing cardiovascular impact of cancer treatments. Dermatological oncology covers skin, hair, sweat gland, and nail cancers medically and surgically. Gastrointestinal oncology manages stomach, colon, rectal, anal canal, liver, gallbladder, and pancreas cancers. Genitourinary oncology handles cancers of the genital and urinary systems. Geriatric oncology focuses on elderly population cancers. Gynecologic oncology serves female reproductive system cancers. Head and Neck oncology treats oral cavity, nasal cavity, oropharynx, hypopharynx, and larynx cancers. Hemato oncology deals with blood cancers and stem cell transplantation. Mathematical oncology applies quantitative methods to biological problems. Molecular oncology uses molecular diagnostic methods for classification. Neuro-oncology focuses on brain cancers. Nuclear medicine oncology diagnoses and treats with radiopharmaceuticals. Ocular oncology treats eye cancers. Pain and palliative oncology alleviates pain in end-stage cases. Pediatric oncology concerns treatment in children. Preventive oncology focuses on epidemiology and prevention strategies. Psycho-oncology addresses psychosocial issues during diagnosis and treatment. Thoracic oncology handles lung, mediastinum, esophagus, and pleura cancers. Veterinary oncology treats cancer in animals.
Up Next
Common questions
What is the origin of the word oncology?
The word oncology comes from the Ancient Greek term ónkos, which means tumor or bulk. It also derives from lógos, meaning study.
How do medical professionals diagnose cancer using specific procedures?
Diagnostic methods often include a biopsy where suspicious neoplastic cells are removed for examination by a pathologist. Other procedures involve endoscopies such as upper gastrointestinal scopes or bronchoscopies to localize tissues. Mammograms, X-rays, CT scanning, MRI scanning, and ultrasound help guide these biopsies.
Which companies lead the pharmaceutical industry in cancer research and treatment?
Most valued companies worldwide include Pfizer, Roche, Merck, AstraZeneca, Novartis, and Bristol-Myers Squibb. These corporations remain active in kinase inhibitors, antibodies, immuno-oncology, and radiopharmaceuticals sectors.
What are the four main divisions that structure clinical practice into distinct areas of focus?
Four main divisions structure clinical practice into distinct areas of focus including Clinical oncology, Medical oncology, Radiation oncology, and Surgical oncology. Sub-specialties expand this framework further including adolescent and young adult oncology, bone and musculoskeletal oncology, breast oncology, and many others.